Consolidation continues its domination of the cannabis space in 2018 as ABcann Global (TSXV:ABCN; OTCQB:ABCCF) seeks to acquire recognized licensed producer (LP) from B.C.

On Monday (July 30) ABcann announced a C$133 million deal for the complete acquisition of Canna Farms, the first B.C. producer to obtain an LP status in 2014.


Canna Farms is a producer with an current capacity of 2,700 kilograms indoor facility located in Hope, B.C. According to ABcann, Canna Farms’ capacity by the end of this year will be 6,900 kilograms thanks to a indoor facility expansion currently under construction.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

The B.C. producer purchase will cost ABcann C$22 million in cash and 92.5 million of its own shares. ABcann’s current production capacity in Napanee, Ontario will nearly triple once the deal is completed, which is expected to close in August.

“Fully funded future capacity by mid-2020 is expected to reach 57,000 kilos ABcann also has plans to supplement this capacity using certified third party suppliers,” Barry Fishman, CEO of ABcann said in a conference call with investors on Tuesday (July 31).

The new company intends to offer premium products for the recreational market, which is set to open in October 17 across Canada.

The new acquisition for ABcann touts a product portfolio of 51 cannabis strains and 5 different oil variations. ABcann’s acquisition indicates some of the value placed on product reviews and the cache a brand may have with established consumers.

Two executives from Canna Farms, Ray Laflamme and Daniel Laflamme, will join ABcann’s leadership team as senior vice president of facilities and engineering and president respectively.

After the deal is completed the two new executives will each own 16.1 percent of the company’s outstanding shares.

Conference call with investors offers more details on acquisition

As part of the conference call with investors, Fishman said a rough combination of the two companies Q2 2018 revenues would provide net sales of over C$4 million.

Canna Farms already has initial supply agreements for recreational cannabis with the provinces of B.C. and Manitoba. Daniel Laflamme said during the call Canna Farms will seek registration with other provinces in the country.

Observers of the industry have voiced support for companies that obtain supply deals as it provides a direct path to reaching adult-use cannabis consumers.

As part of ABcann’s presentation to investors on the new transaction, the Canna Farms medical franchise will bring the total number of patients for the company to 15,000, roughly 5 percent share of the Canadian medical cannabis market according to Fishman.

In March ABcann unveiled a partnership with Choom (CSE:CHOO; OTCQB:CHOOF), including a supply agreement with the retail and brand focussed company.

During the conference call Fishman was asked about the status of this partnership after announcing the Canna Farms acquisition. He answered that he wasn’t ready to speculate on it but guessed it could get “enhanced” thanks to the new acquisition.

Investor takeaway

Since the acquisition was revealed on Monday ABcann’s share price has jumped 11.40 percent as of 11:30 am EST during Tuesday’s trading session to reach a price of C$1.26 per share.

Aaron Salz, CEO of Stoic Advisory which acted as a financial advisory in this acquisition, tweeted the deal creates a new bi-coastal operator with C$110 million in cash for future development and an “international presence.”

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann (CSE:AYUR) entered into a joint venture with Bazelet Group, Israel’s largest privately held medical cannabis company. Ayurcann CEO Igal Sudman shared the company’s excitement about bringing unique terpene-enriched medicinal cannabis to the Canadian marketplace. 

“Canada is a very closed-loop country, and the opportunity to bring a variety of different enhancement and technologically advanced products is very important to us. The relationship that we formed with Bazelet is going to enhance our offerings into the Canadian marketplace,” Sudman said. 

Bazelet has launched multiple lines of terpene-enriched cannabis oils; each one is specifically designed for various indications, symptoms and personal needs. The company’s terpene-enriched products are optimized for women’s health, for elderly population needs, for specific types of pains (muscle, joint, neuropathic) and for improved night sleep. 

According to Sudman, there are a lot of larger companies that have tried to do this, but none have been able to successfully bring innovation into the market. Ayurcann is rapidly forging partnerships with several companies worldwide, including Cannmart, Patient Choice and Kindred Partners.

“We’re growing the business, customer base, relationships and partnerships worldwide. We’re bringing the latest technology into Canada, and enhancing not only our company, but the investors’ value moving forward,” added Sudman. 

Watch the full interview with Ayurcann CEO Igal Sudman above.

Keep reading... Show less

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a new Florida dispensary, the Company’s 91st nationwide.

The latest dispensary, located in Winter Park , supports Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on. The dispensary expands access throughout Central Florida , joining four locations throughout nearby Orlando .

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis extractor, is pleased to announce that the United States Patent and Trademark Office has granted the Company a patent pertaining to the extraction and purification of THC and CBD.

The Company believes it has developed defendable intellectual property around the most efficient methods for producing THC and CBD distillate at scale within a regulated market. Nextleaf owns 15 U.S. patents and has been issued over 80 patents globally.

Keep reading... Show less

Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com

Virtual Investor Conferences in partnership with KCSA Strategic Communications and ATB Capital Markets today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The two-day program begins at 9:30 AM ET on Tuesday June 29 th .

Keep reading... Show less

Acquisition solidifies Canopy Growth’s leadership position in the Canadian recreational market

Canopy Growth Corporation (“Canopy”) (TSX: WEED) (NASDAQ: CGC) and The Supreme Cannabis Company, Inc. (“Supreme”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) are pleased to announce the completion of the previously announced arrangement (the “Arrangement”) whereby Canopy has acquired all of the issued and outstanding common shares of Supreme (the “Supreme Shares”).

Keep reading... Show less